Literature DB >> 27979787

Worrisome high frequency of extended-spectrum beta-lactamase-producing Escherichia coli in community-acquired urinary tract infections: a case-control study.

Franco Castillo-Tokumori1, Claudia Irey-Salgado1, Germán Málaga2.   

Abstract

OBJECTIVES: There has been a sustained and dramatic increase in community-acquired urinary tract infections (CA-UTI) caused by extended-spectrum beta-lactamase (ESBL)-producing bacteria over recent years. Despite this, no studies have been performed in low- or middle-income countries. The main objective of this case-control study was to describe ESBL CA-UTI and its risk factors.
METHODS: Outpatients with CA-UTI seen at the Hospital Cayetano Heredia during 2015 were identified. Patients were contacted by telephone. After consent had been obtained, a questionnaire concerning previously identified risk factors was applied. Univariate and multivariate analyses were conducted using Stata version 13.
RESULTS: The overall frequency of ESBL-producing Escherichia coli was 40.85%. Sixty-seven cases and 105 controls were included in this study. The following main risk factors were identified on multivariate analysis: previous antibiotic use (odds ratio (OR) 3.09), previous hospitalization (OR 2.92), and previous surgery (OR 2.75). Chronic corticosteroid use (OR 24.32, 95% confidence interval 2.39-246.92) was also identified as a risk factor.
CONCLUSIONS: ESBL E. coli accounted for more than 40% of CA-UTIs during 2015. A history of previous hospitalization, surgery, and antibiotic use should be considered when treating this type of infection. Action should be taken to confirm these worrisome results and avoid the major consequences for public health.
Copyright © 2016. Published by Elsevier Ltd.

Entities:  

Keywords:  Community-acquired infection; ESBL; Escherichia coli; Urinary tract infection

Mesh:

Substances:

Year:  2016        PMID: 27979787     DOI: 10.1016/j.ijid.2016.12.007

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  8 in total

1.  Influence of primary care antibiotic prescribing on incidence rates of multidrug-resistant Gram-negative bacteria in hospitalised patients.

Authors:  Munther S Alnajjar; Mamoon A Aldeyab; Michael G Scott; Mary P Kearney; Glenda Fleming; Fiona Glimore; David Farren; James C McElnay
Journal:  Infection       Date:  2019-05-07       Impact factor: 3.553

2.  Comprehensive assessment of holding urine as a behavioral risk factor for UTI in women and reasons for delayed voiding.

Authors:  S Jagtap; S Harikumar; V Vinayagamoorthy; S Mukhopadhyay; A Dongre
Journal:  BMC Infect Dis       Date:  2022-06-06       Impact factor: 3.667

Review 3.  Risk Factors of Extended-Spectrum Beta-Lactamases-Producing Escherichia coli Community Acquired Urinary Tract Infections: A Systematic Review.

Authors:  Stéphanie Larramendy; Valentine Deglaire; Paul Dusollier; Jean-Pascal Fournier; Jocelyne Caillon; François Beaudeau; Leïla Moret
Journal:  Infect Drug Resist       Date:  2020-11-03       Impact factor: 4.003

4.  Carriage of ESBL-producing Enterobacterales in wastewater treatment plant workers and surrounding residents - the AWARE Study.

Authors:  Daloha Rodríguez-Molina; Fanny Berglund; Hetty Blaak; Carl-Fredrik Flach; Merel Kemper; Luminita Marutescu; Gratiela Pircalabioru Gradisteanu; Marcela Popa; Beate Spießberger; Tobias Weinmann; Laura Wengenroth; Mariana Carmen Chifiriuc; D G Joakim Larsson; Dennis Nowak; Katja Radon; Ana Maria de Roda Husman; Andreas Wieser; Heike Schmitt
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-12-13       Impact factor: 5.103

5.  Antimicrobial Susceptibilities of Urinary Extended-spectrum β-lactamase Escherichia coli to Fosfomycin.

Authors:  Nermin Kamal Saeed; Safaa Al Khawaja; Mohammed Al-Biltagi
Journal:  Oman Med J       Date:  2021-11-10

6.  From Pathophysiological Hypotheses to Case-Control Study Design: Resistance from Antibiotic Exposure in Community-Onset Infections.

Authors:  Salam Abbara; Didier Guillemot; Christian Brun-Buisson; Laurence Watier
Journal:  Antibiotics (Basel)       Date:  2022-02-04

7.  Community-Acquired, Extended-Spectrum β-Lactamase-Producing and Extensively Drug-Resistant Escherichia coli in a 28-Year-Old Pyelonephritis Patient Lacking Risk Factors.

Authors:  Connor W Evins; Caroline M Sutton; Sarah T Withers; Jennifer T Grier; Christine M G Schammel; Steven E Fiester
Journal:  Antibiotics (Basel)       Date:  2021-05-05

8.  Antibacterial effect evaluation of moxalactam against extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae with in vitro pharmacokinetics/pharmacodynamics simulation.

Authors:  Chen Huang; Beiwen Zheng; Wei Yu; Tianshui Niu; Tingting Xiao; Jing Zhang; Yonghong Xiao
Journal:  Infect Drug Resist       Date:  2018-01-15       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.